The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of an interdisciplinary goals of care program on hospital outcomes at a comprehensive cancer center during the COVID-19 pandemic: A propensity score analysis.
 
David Hui
Research Funding - Helsinn Healthcare (Inst)
 
Nico Nortje
No Relationships to Disclose
 
Marina C. George
No Relationships to Disclose
 
Kaycee Wilson
No Relationships to Disclose
 
Diana L. Urbauer
No Relationships to Disclose
 
Caitlin Lenz
No Relationships to Disclose
 
Susannah Kish Wallace
No Relationships to Disclose
 
Clark Andersen
No Relationships to Disclose
 
Tito R. Mendoza
Honoraria - Amgen
Consulting or Advisory Role - Bristol Myers Squibb
Research Funding - Bayer (Inst); Lilly (Inst)
 
Sajid Haque
No Relationships to Disclose
 
Sairah Ahmed
Honoraria - Novartis; Seagen
Consulting or Advisory Role - Myeloid Therapeutics; Sanofi; Tessa Therapeutics
Research Funding - Merck (Inst); Seagen (Inst); Tessa Therapeutics (Inst)
 
Marvin Delgado Guay
No Relationships to Disclose
 
Shalini Dalal
No Relationships to Disclose
 
Nisha Rathi
No Relationships to Disclose
 
Akhila Sunkepally Reddy
No Relationships to Disclose
 
Jennifer Leigh McQuade
Honoraria - Bristol-Myers Squibb/Roche; Merck
Consulting or Advisory Role - Bristol Myer Squibb; Roche Pharma AG
Travel, Accommodations, Expenses - Merck
 
Christopher Flowers
Consulting or Advisory Role - Abbvie; Bayer; BeiGene; Celgene; Denovo Biopharma; Epizyme; Genentech/Roche; Gilead Sciences; Karyopharm Therapeutics; Pharmacyclics/Janssen; Spectrum Pharmaceuticals
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Alimera Sciences (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Millennium (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst); Xencor (Inst)
 
Peter W. T. Pisters
No Relationships to Disclose
 
Eduardo Bruera
Research Funding - PharmaCann (Inst)